FDA No Longer Supports Compounded Pergolide Production
Erica Larson
March 28, 2012
The change comes several months after the FDA approved a pergolide mesylate tablet for use in horses.
The change comes several months after the FDA approved a pergolide mesylate tablet for use in horses.
Even when NSAIDs are used appropriately, the drugs can still prove damaging to the patient.
Research indicates that combining NSAIDs achieved no better results than using either drug alone.
The panel will provide insight on various health issues for the CHRB Medication and Track Safety Committee.
One researcher concluded that when dosing PBZ in the horse, “More is not better. Less is less effective.”
Previous studies failed to achieve in horses what are considered therapeutic tramadol plasma levels in humans.
Buscopan has been accepted as effective treatment for simple choke in other countries for 40 years.
Goals include discussion on maximizing drug efficacy and minimizing development of parasitic resistance.
The research pinpointed how long it took for some commonly used therapeutic drugs to clear a horse’s system.
This procedure involves intravenous antibiotic delivery to the lower limb via a vein close to the trauma site.
Ensure a bacterial infection that will respond to antibiotics is actually present before beginning treatment.
Topical anti-inflammatories, hyaluronic acid, and shock wave therapy are among the popular treatment options.
Panelists said there is no scientific evidence supporting a ban on the use of furosemide on race day.
The British Horseracing Authority announced in late 2011 four new detection times for common medications.
The Equine Health, Welfare, Integrity, and Research Subcommittee released a statement on welfare in racing.
The study will test a novel neutriceutical for the treatment of lameness in horses due to osteoarthritis.
Stay on top of the most recent Horse Health news with
